Synthetic ACTH therapy in allergic diseases
Hajós, M.
Orvosi Hetilap 111(22): 1268-1272
1970
ISSN/ISBN: 0030-6002 PMID: 4318341 Document Number: 25660
Document emailed within 1 workday
Related Documents
Artese, R.; De Laszlo, M.H.; Molocznik, I.; Varela, J.; Guitelman, A.; Brussino, M.; Dickmann, G.H.; Montes, M.E. 1971: Pharmacodynamic evaluation of synthetic prolonged-action ACTH on the adrenal function of patients with hypothalamo-pituitary pathology. Comparative study of synthetic ACTH and extra-delayed-action gel Prensa Medica Argentina 57(46): 2088-2097Frank, A. 1971: Synthetic depot-ACTH in the treatment of obstructive bronchial diseases Wiener Medizinische Wochenschrift 121(47): 844-848
Pozzi, E.; Scala, C. 1980: The use of sequence 1-39 human synthetic ACTH in therapy of asthmatic syndromes La Clinica Terapeutica 93(3): 319-327
Feldman, E.C.; Stabenfeldt, G.H.; Farver, T.B.; Addiego, L.A. 1982: Comparison of aqueous porcine ACTH with synthetic ACTH in adrenal stimulation tests of the female dog American Journal of Veterinary Research 43(3): 522-524
Syskov, I.V.; Romanovskiĭ, P.I.; Vosekalna, I.A.; Skuin'sh, A.A.; Ratkevich, M.P. 1984: Structural and functional organization of ACTH: synthesis and properties of analogs of ACTH-(11-24)-tetradeca- and ACTH-(1-24)-tetracosapeptides containing hexa-amino acids instead of a natural sequence of ACTH 19-24 amino acids Bioorganicheskaia Khimiia 10(5): 618-625
Mutina, E.S. 1975: Non-specific therapy of allergic diseases Sovetskaia Meditsina 8: 48-52
Andersson, K.E.; Arner, B.; Hedner, P.; Mulder, J.L. 1972: Effects of 8-lysine-vasopressin and synthetic analogues of release of ACTH Acta Endocrinologica 69(4): 640-648
Versteeg, D.H.; Gispen, W.H.; Schotmann, P.; Witter, A.; de Wied, D. 1972: Hypophysectomy and rat brain metabolism: effects of synthetic ACTH analogs Advances in Biochemical Psychopharmacology 6: 219-239
Spornraft, P.; Ring, J. 1991: Immunoglobulin therapy in IgE-mediated allergic diseases Der Hautarzt; Zeitschrift für Dermatologie Venerologie und verwandte Gebiete 42(10): 605-606
Leonard, B.E. 1974: The effect of two synthetic ACTH analogues on the metabolism of biogenic amines in the rat brain Archives Internationales de Pharmacodynamie et de Therapie 207(2): 242-253
Réfi, M.; Héjjas, M.; Koiss, I. 1971: Synthetic human corticotropin (alpha-h ACTH) and bacterial phagocytosis of leukocytes Orvosi Hetilap 112(23): 1330-1332
Brambilla, F.; Giardini, M.; Lenti, C. 1972: Use of synthetic ACTH (Synacthen depot) in the treatment of various forms of epilepsy in children Rivista di Neurologia 42(6): 542-551
Stolecke, H. 1971: Efficiency, dose relation and depot effect of a synthetic polypeptide with ACTH action Zeitschrift für Kinderheilkunde 111(1): 21-28
Werner, M. 1973: The diagnosis and therapy of allergic factors in bronchial diseases Medizinische Klinik 68(49): 1630-1635
Asha Devi, S. 1988: Effect of a synthetic short-chain ACTH 1-17 (HOE 433) on isoproterenol-induced myocardial infarction in rats Indian Journal of Experimental Biology 26(9): 685-687
Hawkins, J.B.; Burch, W.M. 1989: Rapid tests of adrenocortical function. Intravenous versus intramuscular administration of synthetic ACTH North Carolina Medical Journal 50(6): 306-308
Vecci, E.; Agostino, A.; Ricci, C.; Iacobelli, A. 1977: Endocrine aspects of puberty. Modifications of gonadotropins (LH, FSH), testosterone and cortisol circulating after ACTH and synthetic LH-RH Minerva Medica 68(57): 3827-3832
Mutina, E.S. 1976: Further prospects for the development of specific diagnosis and therapy of allergic diseases Sovetskaia Meditsina 7: 3-7
Maĭchuk, I.F. 2003: The state-of-the art and prospects for the pharmacological therapy of infectious and allergic eye diseases Vestnik Rossiiskoi Akademii Meditsinskikh Nauk 5: 23-28
Serafini, U.; Bonini, S. 1974: Corticoid therapy in allergic diseases. Clinical evaluation of a chronopharmacological attempt Chronobiologia 1(Suppl 1): 399-406